Selected research
Market Structure
Global Personalized Therapy Biosimulation Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Personalized Therapy Biosimulation Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Personalized Therapy Biosimulation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Personalized Therapy Biosimulation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Personalized Therapy Biosimulation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Personalized Therapy Biosimulation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Personalized Therapy Biosimulation Platform include Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology, Chemical Computing Group ULC(CCG), Evidera, AnyLogic and Shanghai Lide, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Personalized Therapy Biosimulation Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Personalized Therapy Biosimulation Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Personalized Therapy Biosimulation Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Personalized Therapy Biosimulation Platform market size, projected growth trends, production technologies, key applications, and end-use industries.
Personalized Therapy Biosimulation Platform Segment by Company
Schrodinger
In Silico Biosciences
Genedata
Physiomics
Insilico Biotechology
Chemical Computing Group ULC(CCG)
Evidera
AnyLogic
Shanghai Lide
Cellworks Group
Certara
Simulation Plus
Personalized Therapy Biosimulation Platform Segment by Type
Pharmacokinetic
Pharmacoeconomics
Personalized Therapy Biosimulation Platform Segment by Application
Pharmaceutical and Biotech Companies
Research Institutions
Hospital
Others
Personalized Therapy Biosimulation Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Therapy Biosimulation Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Personalized Therapy Biosimulation Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Therapy Biosimulation Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Personalized Therapy Biosimulation Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personalized Therapy Biosimulation Platform industry.
Chapter 3: Detailed analysis of Personalized Therapy Biosimulation Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Therapy Biosimulation Platformrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmacokinetic
- Pharmacoeconomics
Applications
- Pharmaceutical and Biotech Companies
- Research Institutions
- Hospital
- Others
Companies covered
- Schrodinger
- In Silico Biosciences
- Genedata
- Physiomics
- Insilico Biotechology
- Chemical Computing Group ULC(CCG)
- Evidera
- AnyLogic
- Shanghai Lide
- Cellworks Group
- Certara
- Simulation Plus
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Pharmacokinetic
- 1.2.3 Pharmacoeconomics
- 1.3 Market Analysis by Application
- 1.3.1 Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical and Biotech Companies
- 1.3.3 Research Institutions
- 1.3.4 Hospital
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Personalized Therapy Biosimulation Platform Growth Trends by Region
- 1.5.1 Global Personalized Therapy Biosimulation Platform Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Personalized Therapy Biosimulation Platform Market Size by Region (2021-2026)
- 1.5.3 Personalized Therapy Biosimulation Platform Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Personalized Therapy Biosimulation Platform Market Dynamics
- 2.1 Personalized Therapy Biosimulation Platform Industry Trends
- 2.2 Personalized Therapy Biosimulation Platform Industry Drivers
- 2.3 Personalized Therapy Biosimulation Platform Industry Opportunities and Challenges
- 2.4 Personalized Therapy Biosimulation Platform Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Personalized Therapy Biosimulation Platform Revenue by Company (2021-2026)
- 3.2 Global Personalized Therapy Biosimulation Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Personalized Therapy Biosimulation Platform Key Company Head office and Area Served
- 3.4 Global Personalized Therapy Biosimulation Platform Company, Product Type & Application
- 3.5 Global Personalized Therapy Biosimulation Platform Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Personalized Therapy Biosimulation Platform Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Personalized Therapy Biosimulation Platform Players Market Share by Revenue in 2025
- 3.6.3 2025 Personalized Therapy Biosimulation Platform Tier 1, Tier 2, and Tier 3
4 Personalized Therapy Biosimulation Platform Market by Type
- 4.1 Global Personalized Therapy Biosimulation Platform Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Personalized Therapy Biosimulation Platform Market Size by Type (2021-2032)
- 4.3 Global Personalized Therapy Biosimulation Platform Market Size Share by Type (2021-2032)
5 Personalized Therapy Biosimulation Platform Market by Application
- 5.1 Global Personalized Therapy Biosimulation Platform Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Personalized Therapy Biosimulation Platform Market Size by Application (2021-2032)
- 5.3 Global Personalized Therapy Biosimulation Platform Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Schrodinger
- 6.1.1 Schrodinger Company Information
- 6.1.2 Schrodinger Business Overview
- 6.1.3 Schrodinger Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Schrodinger Personalized Therapy Biosimulation Platform Product Portfolio
- 6.1.5 Schrodinger Recent Developments
- 6.2 In Silico Biosciences
- 6.2.1 In Silico Biosciences Company Information
- 6.2.2 In Silico Biosciences Business Overview
- 6.2.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 In Silico Biosciences Personalized Therapy Biosimulation Platform Product Portfolio
- 6.2.5 In Silico Biosciences Recent Developments
- 6.3 Genedata
- 6.3.1 Genedata Company Information
- 6.3.2 Genedata Business Overview
- 6.3.3 Genedata Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Genedata Personalized Therapy Biosimulation Platform Product Portfolio
- 6.3.5 Genedata Recent Developments
- 6.4 Physiomics
- 6.4.1 Physiomics Company Information
- 6.4.2 Physiomics Business Overview
- 6.4.3 Physiomics Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Physiomics Personalized Therapy Biosimulation Platform Product Portfolio
- 6.4.5 Physiomics Recent Developments
- 6.5 Insilico Biotechology
- 6.5.1 Insilico Biotechology Company Information
- 6.5.2 Insilico Biotechology Business Overview
- 6.5.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Insilico Biotechology Personalized Therapy Biosimulation Platform Product Portfolio
- 6.5.5 Insilico Biotechology Recent Developments
- 6.6 Chemical Computing Group ULC(CCG)
- 6.6.1 Chemical Computing Group ULC(CCG) Company Information
- 6.6.2 Chemical Computing Group ULC(CCG) Business Overview
- 6.6.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product Portfolio
- 6.6.5 Chemical Computing Group ULC(CCG) Recent Developments
- 6.7 Evidera
- 6.7.1 Evidera Company Information
- 6.7.2 Evidera Business Overview
- 6.7.3 Evidera Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Evidera Personalized Therapy Biosimulation Platform Product Portfolio
- 6.7.5 Evidera Recent Developments
- 6.8 AnyLogic
- 6.8.1 AnyLogic Company Information
- 6.8.2 AnyLogic Business Overview
- 6.8.3 AnyLogic Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 AnyLogic Personalized Therapy Biosimulation Platform Product Portfolio
- 6.8.5 AnyLogic Recent Developments
- 6.9 Shanghai Lide
- 6.9.1 Shanghai Lide Company Information
- 6.9.2 Shanghai Lide Business Overview
- 6.9.3 Shanghai Lide Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Shanghai Lide Personalized Therapy Biosimulation Platform Product Portfolio
- 6.9.5 Shanghai Lide Recent Developments
- 6.10 Cellworks Group
- 6.10.1 Cellworks Group Company Information
- 6.10.2 Cellworks Group Business Overview
- 6.10.3 Cellworks Group Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Cellworks Group Personalized Therapy Biosimulation Platform Product Portfolio
- 6.10.5 Cellworks Group Recent Developments
- 6.11 Certara
- 6.11.1 Certara Company Information
- 6.11.2 Certara Business Overview
- 6.11.3 Certara Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Certara Personalized Therapy Biosimulation Platform Product Portfolio
- 6.11.5 Certara Recent Developments
- 6.12 Simulation Plus
- 6.12.1 Simulation Plus Company Information
- 6.12.2 Simulation Plus Business Overview
- 6.12.3 Simulation Plus Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Simulation Plus Personalized Therapy Biosimulation Platform Product Portfolio
- 6.12.5 Simulation Plus Recent Developments
7 North America
- 7.1 North America Personalized Therapy Biosimulation Platform Market Size (2021-2032)
- 7.2 North America Personalized Therapy Biosimulation Platform Market Size by Type
- 7.2.1 North America Personalized Therapy Biosimulation Platform Market Size by Type (2021-2026)
- 7.2.2 North America Personalized Therapy Biosimulation Platform Market Size by Type (2027-2032)
- 7.2.3 North America Personalized Therapy Biosimulation Platform Market Share by Type (2021-2032)
- 7.3 North America Personalized Therapy Biosimulation Platform Market Size by Application
- 7.3.1 North America Personalized Therapy Biosimulation Platform Market Size by Application (2021-2026)
- 7.3.2 North America Personalized Therapy Biosimulation Platform Market Size by Application (2027-2032)
- 7.3.3 North America Personalized Therapy Biosimulation Platform Market Share by Application (2021-2032)
- 7.4 North America Personalized Therapy Biosimulation Platform Market Size by Country
- 7.4.1 North America Personalized Therapy Biosimulation Platform Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Personalized Therapy Biosimulation Platform Market Size by Country (2021-2026)
- 7.4.3 North America Personalized Therapy Biosimulation Platform Market Size by Country (2027-2032)
- 7.4.4 North America Personalized Therapy Biosimulation Platform Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Personalized Therapy Biosimulation Platform Market Size (2021-2032)
- 8.2 Europe Personalized Therapy Biosimulation Platform Market Size by Type
- 8.2.1 Europe Personalized Therapy Biosimulation Platform Market Size by Type (2021-2026)
- 8.2.2 Europe Personalized Therapy Biosimulation Platform Market Size by Type (2027-2032)
- 8.2.3 Europe Personalized Therapy Biosimulation Platform Market Share by Type (2021-2032)
- 8.3 Europe Personalized Therapy Biosimulation Platform Market Size by Application
- 8.3.1 Europe Personalized Therapy Biosimulation Platform Market Size by Application (2021-2026)
- 8.3.2 Europe Personalized Therapy Biosimulation Platform Market Size by Application (2027-2032)
- 8.3.3 Europe Personalized Therapy Biosimulation Platform Market Share by Application (2021-2032)
- 8.4 Europe Personalized Therapy Biosimulation Platform Market Size by Country
- 8.4.1 Europe Personalized Therapy Biosimulation Platform Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Personalized Therapy Biosimulation Platform Market Size by Country (2021-2026)
- 8.4.3 Europe Personalized Therapy Biosimulation Platform Market Size by Country (2027-2032)
- 8.4.4 Europe Personalized Therapy Biosimulation Platform Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Personalized Therapy Biosimulation Platform Market Size (2021-2032)
- 9.2 China Personalized Therapy Biosimulation Platform Market Size by Type
- 9.2.1 China Personalized Therapy Biosimulation Platform Market Size by Type (2021-2026)
- 9.2.2 China Personalized Therapy Biosimulation Platform Market Size by Type (2027-2032)
- 9.2.3 China Personalized Therapy Biosimulation Platform Market Share by Type (2021-2032)
- 9.3 China Personalized Therapy Biosimulation Platform Market Size by Application
- 9.3.1 China Personalized Therapy Biosimulation Platform Market Size by Application (2021-2026)
- 9.3.2 China Personalized Therapy Biosimulation Platform Market Size by Application (2027-2032)
- 9.3.3 China Personalized Therapy Biosimulation Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Personalized Therapy Biosimulation Platform Market Size (2021-2032)
- 10.2 Asia Personalized Therapy Biosimulation Platform Market Size by Type
- 10.2.1 Asia Personalized Therapy Biosimulation Platform Market Size by Type (2021-2026)
- 10.2.2 Asia Personalized Therapy Biosimulation Platform Market Size by Type (2027-2032)
- 10.2.3 Asia Personalized Therapy Biosimulation Platform Market Share by Type (2021-2032)
- 10.3 Asia Personalized Therapy Biosimulation Platform Market Size by Application
- 10.3.1 Asia Personalized Therapy Biosimulation Platform Market Size by Application (2021-2026)
- 10.3.2 Asia Personalized Therapy Biosimulation Platform Market Size by Application (2027-2032)
- 10.3.3 Asia Personalized Therapy Biosimulation Platform Market Share by Application (2021-2032)
- 10.4 Asia Personalized Therapy Biosimulation Platform Market Size by Country
- 10.4.1 Asia Personalized Therapy Biosimulation Platform Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Personalized Therapy Biosimulation Platform Market Size by Country (2021-2026)
- 10.4.3 Asia Personalized Therapy Biosimulation Platform Market Size by Country (2027-2032)
- 10.4.4 Asia Personalized Therapy Biosimulation Platform Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Type
- 11.2.1 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Application
- 11.3.1 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country
- 11.4.1 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Personalized Therapy Biosimulation Platform Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst